Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

By J. Lieberman, T. Scott Stroup, J. McEvoy, M. Swartz, Robert A. Rosenheck, D. Perkins, R. Keefe, S. Davis, C. E. Davis, B. Lebowitz and 2 more. New England Journal of Medicine, 2005

5,425 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Pharmacology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/0220d1b8b8e5644e3b5258e4df2fcaf90ac00b70

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacology

In Psychiatry and Mental health

Citations in the corpus

Animal models of schizophrenia (2011, background): “However, multi-site, double-blind studies comparing several second-generation antipsychotics with a typical antipsychotic, perphenazine, failed to substantiate any major therapeutic advantage of the former (Lieberman et al., 2005).”
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (2006, methodology): “Treatment groups were compared with Cox proportional hazards regression models ( 11 ), with adjustment for whether the patient had an exacerbation in the 3 months before entering the study, tardive dyskinesia status, and whether the patient was initially randomly assigned to perphenazine (and thus h”
Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study (2012, methodology): “The details of the design and protocol of the CATIE study have been described in detail elsewhere (Swartz et al., 2003; Stroup et al., 2003, 2006; Lieberman et al., 2005; McEvoy et al., 2006); thus, here we give a brief review of the CATIE study as it pertains to the scientific question of interest…”
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. (2010, background): “A comparison across 4 studies showed IM haloperidol to be equally effective as IM aripiprazole and olanzapine but with a higher incidence of EPS.105,107 Ziprasidone has not been compared with an active comparator.”
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis (2006, background): “Existing drugs are poorly tolerated and exhibit little differences in efficacy (Lieberman et al., 2005).”
Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology (2009, neutral): “The use of olanzapine and quetiapine is particularly associated with unfavourable metabolic indices, especially when the patient population is obese (Lieberman et al., 2005).”
Adaptive Interventions in Child and Adolescent Mental Health (2016, background): “The Clinical Antipsychotics Trial of Intervention Effectiveness in schizophrenia (Lieberman et al., 2005; Shortreed & Moodie, 2012) and the Sequenced Treatment Alternatives to Relieve Depression in depression (Lavori et al.”
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011, result): “There is a hierarchy for risk of weight gain with AP that has been confirmed in different studies and meta-analyses (88,92,100-106).”
Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research (2014, background): “An example of an early precursor to the SMART is the Clinical Antipsychotics Trial of Intervention Effectiveness (CATIE) [54] in chronic schizophrenia.”
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, methodology): “…action Ho et al. 1999; Ishigooka et al. 2001; Jones et al. 2006; Kahn et al. 2008; Kane et al. 2007a; Kraus et al. 2005; Leucht et al. 2009b, 2009d; Lieberman et al. 2003a, 2005; Martin et al. 2002; Mauri et al. 2006; McCue et al. 2006; Mortimer et al. 2004; Revicki et al. 1999; Sacchetti et al.…”